We can't find the internet
Attempting to reconnect
17485.1 PFLS-LS
Anti-MAG Neuropathy: Development of a Therapeutic Glycopolymer
Résumé
Anti-MAG Neuropathy: Development of a Therapeutic Glycopolymer
Textes supplémentaires
Abstract
The aim of this project is to define preclinical lead candidates for the treatment of anti-myelin-associated|glycoprotein (MAG) neuropathy, a disabling IgM autoantibody-mediated autoimmune disorder of the|peripheral nervous system. Currently, there is no effective treatment and agents to block/deplete the|pathogenic autoantibodies are of substancial clinical interest. Several lead candidates (glycopolymers) will|be synthesized and evaluated in an animal model of the disease.
Participants
Ruben Herrendorf
Wirtschaftspartner
ruben.herrendorff@unibas.ch
Polyneuron Pharmaceuticals AG Ruben Herrendorf Hochbergerstrasse 60c 4057 Basel BS CH
Beat Ernst
Kontaktperson
beat.ernst@unibas.ch
Universität Basel Beat Ernst Klingelbergstrasse 50 4056 Basel BS CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2015-03-31
- Date de fin
- 2017-09-30
- Coûts totaux approuvés
- CHF 418900.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%